Inside the efforts to rescue a rare disease gene therapy
Several patients are navigating ways to access innovative gene therapies with the help of enterprising research and nonprofit organisations.
Cytiva-Cell & Gene Therapy WP 2
New study suggests CAR-T therapy monitoring time could be slashed
Left in limbo: When pharma halts rare disease research
APAC leaps ahead in adoptive cell therapy space
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Cellenkos links with Mount Sinai to explore CK0804 for myelofibrosis
FDA fast-tracks Invectys’ CAR-T therapy for renal cell carcinoma
Alexion to acquire Pfizer’s rare disease gene therapies for $1bn
